trending Market Intelligence /marketintelligence/en/news-insights/trending/6uYynv_UfBFF4I47uF2pOQ2 content esgSubNav
In This List

Knight Therapeutics raises over C$100M in bought-deal offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Knight Therapeutics raises over C$100M in bought-deal offering

Knight Therapeutics Inc. raised C$100.1 million in a bought-deal offering of shares led by GMP Securities LP and Cormark Securities Inc.

The company issued 10,005,000 common shares at C$10 apiece, including 1,305,000 securities that were issued as part of a fully exercised overallotment option.

Knight Therapeutics will use amounts raised to fund future growth and for general corporate purposes.

Bloom Burton & Co. Ltd., CIBC World Markets Inc., Laurentian Bank Securities Inc., Mackie Research Capital Corp., National Bank Financial Inc., Paradigm Capital Inc., Scotia Capital Inc. and TD Securities Inc. also participated in the offering.